Developing and Strengthening Cannabis Warnings: Warning Message Testing
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
- Comportemental: Constituents
- Comportemental: Cognitive Functioning
- Comportemental: Cardiovascular Health
- Comportemental: Motor Vehicle Crashes
- Comportemental: Dependence
- Comportemental: Psychosis and Schizophrenia
- Comportemental: Mental Health
- Comportemental: Reproductive Health
- Comportemental: Respiratory Health
- Comportemental: Edibles
- Comportemental: Cannabis Hyperemesis Syndrome
- Comportemental: Control
Description détaillée
The purpose of this activity is to identify promising cannabis warning messages from different themes.
Setting: An online survey of adults who live in the United States.
Participants: An estimated N=1500 adults who live in the United States, including both people who use cannabis and those who do not use cannabis. Participants will be recruited by Qualtrics Services. Participants who are eligible for the study will view a consent form as part of the survey and check a box to indicate that they agree to participate in the study. Once the participant has completed consent, they will be able to begin the survey.
Procedures: Participants will complete a within-subjects experiment in which they view and rate cannabis warning messages from different themes. Participants will be screened for inclusion and answer questions on demographic information and susceptibility to cannabis use. Participants will then be randomly assigned to view 7 cannabis warning messages from different themes developed as part of previous study activities. After viewing each cannabis warning message, participants will rate the message on awareness, clarity, believability, cognitive elaboration, perceived message effectiveness, and reactance. There will be a total of 11 warning themes plus control. After viewing and rating their assigned cannabis warning messages, participants will answer additional questions about cannabis risk perceptions and use behavior (if applicable), additional demographic information, and about their use of tobacco and alcohol. The survey will take 15-20 minutes.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Sarah D Kowitt, PhD, MPH
- Numéro de téléphone: 919-974-4980
- E-mail: kowitt@unc.edu
Lieux d'étude
-
-
North Carolina
-
Chapel Hill, North Carolina, États-Unis, 27514
- University of North Carolina at Chapel Hill
-
Contact:
- Sarah D Kowitt, PhD, MPH
- Numéro de téléphone: 919-974-4980
- E-mail: kowitt@unc.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 18 years of age and older
- Live in the United States
Exclusion Criteria:
- Age less than 18 years of age
- Does not live in the United States
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Cannabis warning messages
Participants will view and rate 7 cannabis warning messages. The cannabis warning messages cover 11 different themes plus a control theme and were identified in a previous study activity. Theme 1: Constituents Theme 2: Cognitive Functioning Theme 3: Cardiovascular Health Theme 4: Motor Vehicle Crashes Theme 5: Dependence Theme 6: Psychosis and Schizophrenia Theme 7: Mental Health Theme 8: Reproductive Health Theme 9: Respiratory Health Theme 10: Edibles Theme 11: Cannabis Hyperemesis Syndrome Theme 12: Control |
Participants will view and rate a message about constituents.
Participants will view and rate a message about cognitive functioning.
Participants will view and rate a message about cardiovascular health.
Participants will view and rate a message about motor vehicle crashes.
Participants will view and rate a message about dependence.
Participants will view and rate a message about psychosis and schizophrenia.
Participants will view and rate a message about mental health.
Participants will view and rate a message about reproductive health.
Participants will view and rate a message about respiratory health.
Participants will view and rate a message about edibles.
Participants will view and rate a message about cannabis hyperemesis syndrome.
Participants will view and rate a control message.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cognitive Elaboration
Délai: Baseline (one time online survey)
|
A one item measure of cognitive elaboration to assess how much a message makes the participant think about the health risks of cannabis.
Response options are on a 5-point scale from 5='A great deal' to 1= 'Not at all', with higher scores indicating higher cognitive elaboration.
|
Baseline (one time online survey)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Perceived Message Effectiveness
Délai: Baseline (one time online survey)
|
This survey item assesses perceived message effectiveness in terms of how concerned the message makes the participant feel about the health effects of using cannabis.
Response options are on a 5-point scale from 5='A great deal' to 1='Not at all' with higher scores indicating higher perceived message effectiveness.
|
Baseline (one time online survey)
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Clarity
Délai: Baseline (one time online survey)
|
This survey item assesses the extent to which a participant feels that the message is clear.
Response options are on a 5-point scale from 5='Very clear' to 1='Not clear at all' with higher scores indicating that a message is more clear.
|
Baseline (one time online survey)
|
|
Believability
Délai: Baseline (one time online survey)
|
This survey item assesses the extent to which a participant feels that the message is believable.
Response options are on a 5-point scale from 5='Very believable' to 1='Not at all believable' with higher scores indicating that a message is more believable.
|
Baseline (one time online survey)
|
|
Reactance
Délai: Baseline (one time online survey)
|
This survey item assesses reactance in terms of how much a participant is annoyed by the message.
Response options are on a 5-point scale from 5='A great deal' to 1='Not at all' with higher scores indicating higher reactance to the message.
|
Baseline (one time online survey)
|
Collaborateurs et enquêteurs
Collaborateurs
Les enquêteurs
- Chercheur principal: Sarah D Kowitt, PhD, MPH, University of North Carolina, Chapel Hill
- Chercheur principal: Leah M Ranney, PhD, MA, University of North Carolina, Chapel Hill
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Les troubles mentaux
- Troubles liés à une substance
- Troubles induits chimiquement
- Comportement
- Consommation de marijuana
- Abus de marijuana
- Santé publique
- Environnement et santé publique
- Services de santé
- Conseils de soins de santé
- Caractéristiques de la population
- Réhabilitation
- État de santé
- Démographie
- Mesures épidémiologiques
- Activités de la vie quotidienne
- Santé
- État fonctionnel
- Santé mentale
- Reproductive Health
Autres numéros d'identification d'étude
- 24-1616
- R01DA058003 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .